nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—Mitiglinide—PPARG—liver cancer	0.00925	0.371	CrCbGaD
Cilazapril—Benazepril—MTHFR—liver cancer	0.00921	0.369	CrCbGaD
Cilazapril—Rectal haemorrhage—Doxorubicin—liver cancer	0.00482	0.00494	CcSEcCtD
Cilazapril—Hypertension—Sorafenib—liver cancer	0.0048	0.00492	CcSEcCtD
Cilazapril—Myalgia—Sorafenib—liver cancer	0.00473	0.00486	CcSEcCtD
Cilazapril—Arthralgia—Sorafenib—liver cancer	0.00473	0.00486	CcSEcCtD
Cilazapril—Nateglinide—PPARG—liver cancer	0.00471	0.189	CrCbGaD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.0047	0.00482	CcSEcCtD
Cilazapril—Dry mouth—Sorafenib—liver cancer	0.00463	0.00475	CcSEcCtD
Cilazapril—Hyperkalaemia—Epirubicin—liver cancer	0.00462	0.00474	CcSEcCtD
Cilazapril—Atrioventricular block—Doxorubicin—liver cancer	0.00448	0.0046	CcSEcCtD
Cilazapril—Shock—Sorafenib—liver cancer	0.00447	0.00458	CcSEcCtD
Cilazapril—Thrombocytopenia—Sorafenib—liver cancer	0.00444	0.00456	CcSEcCtD
Cilazapril—Skin disorder—Sorafenib—liver cancer	0.00441	0.00452	CcSEcCtD
Cilazapril—Anorexia—Sorafenib—liver cancer	0.00433	0.00444	CcSEcCtD
Cilazapril—Cramps of lower extremities—Epirubicin—liver cancer	0.00432	0.00443	CcSEcCtD
Cilazapril—Hyperkalaemia—Doxorubicin—liver cancer	0.00427	0.00438	CcSEcCtD
Cilazapril—Rash maculo-papular—Epirubicin—liver cancer	0.00427	0.00438	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00414	0.00424	CcSEcCtD
Cilazapril—Abnormal vision—Epirubicin—liver cancer	0.0041	0.00421	CcSEcCtD
Cilazapril—Dyspnoea—Sorafenib—liver cancer	0.00405	0.00415	CcSEcCtD
Cilazapril—Cramps of lower extremities—Doxorubicin—liver cancer	0.004	0.0041	CcSEcCtD
Cilazapril—Dyspepsia—Sorafenib—liver cancer	0.004	0.0041	CcSEcCtD
Cilazapril—Rash maculo-papular—Doxorubicin—liver cancer	0.00395	0.00406	CcSEcCtD
Cilazapril—Decreased appetite—Sorafenib—liver cancer	0.00395	0.00405	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Sorafenib—liver cancer	0.00392	0.00402	CcSEcCtD
Cilazapril—Fatigue—Sorafenib—liver cancer	0.00391	0.00401	CcSEcCtD
Cilazapril—Hepatic function abnormal—Epirubicin—liver cancer	0.00391	0.004	CcSEcCtD
Cilazapril—Photosensitivity—Epirubicin—liver cancer	0.00389	0.00399	CcSEcCtD
Cilazapril—Pain—Sorafenib—liver cancer	0.00388	0.00398	CcSEcCtD
Cilazapril—Constipation—Sorafenib—liver cancer	0.00388	0.00398	CcSEcCtD
Cilazapril—Vascular purpura—Epirubicin—liver cancer	0.00382	0.00391	CcSEcCtD
Cilazapril—Abnormal vision—Doxorubicin—liver cancer	0.00379	0.00389	CcSEcCtD
Cilazapril—Cardiac failure congestive—Epirubicin—liver cancer	0.00376	0.00386	CcSEcCtD
Cilazapril—Gastrointestinal pain—Sorafenib—liver cancer	0.00371	0.00381	CcSEcCtD
Cilazapril—Renal failure acute—Epirubicin—liver cancer	0.0037	0.00379	CcSEcCtD
Cilazapril—Hot flush—Epirubicin—liver cancer	0.00365	0.00374	CcSEcCtD
Cilazapril—Menopausal symptoms—Epirubicin—liver cancer	0.00362	0.00371	CcSEcCtD
Cilazapril—Hepatic function abnormal—Doxorubicin—liver cancer	0.00361	0.00371	CcSEcCtD
Cilazapril—Urticaria—Sorafenib—liver cancer	0.00361	0.0037	CcSEcCtD
Cilazapril—Photosensitivity—Doxorubicin—liver cancer	0.0036	0.00369	CcSEcCtD
Cilazapril—Abdominal pain—Sorafenib—liver cancer	0.00359	0.00368	CcSEcCtD
Cilazapril—Renal impairment—Epirubicin—liver cancer	0.00359	0.00368	CcSEcCtD
Cilazapril—Purpura—Epirubicin—liver cancer	0.00354	0.00363	CcSEcCtD
Cilazapril—Vascular purpura—Doxorubicin—liver cancer	0.00353	0.00362	CcSEcCtD
Cilazapril—Cardiac failure—Epirubicin—liver cancer	0.0035	0.00359	CcSEcCtD
Cilazapril—Cerebrovascular accident—Epirubicin—liver cancer	0.00348	0.00357	CcSEcCtD
Cilazapril—Cardiac failure congestive—Doxorubicin—liver cancer	0.00348	0.00357	CcSEcCtD
Cilazapril—Renal failure acute—Doxorubicin—liver cancer	0.00342	0.00351	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00341	0.0035	CcSEcCtD
Cilazapril—Hot flush—Doxorubicin—liver cancer	0.00338	0.00346	CcSEcCtD
Cilazapril—Migraine—Epirubicin—liver cancer	0.00336	0.00345	CcSEcCtD
Cilazapril—Menopausal symptoms—Doxorubicin—liver cancer	0.00335	0.00343	CcSEcCtD
Cilazapril—Hypersensitivity—Sorafenib—liver cancer	0.00334	0.00343	CcSEcCtD
Cilazapril—Renal impairment—Doxorubicin—liver cancer	0.00332	0.0034	CcSEcCtD
Cilazapril—Face oedema—Epirubicin—liver cancer	0.00329	0.00338	CcSEcCtD
Cilazapril—Purpura—Doxorubicin—liver cancer	0.00328	0.00336	CcSEcCtD
Cilazapril—Asthenia—Sorafenib—liver cancer	0.00326	0.00334	CcSEcCtD
Cilazapril—Cardiac failure—Doxorubicin—liver cancer	0.00324	0.00332	CcSEcCtD
Cilazapril—Cerebrovascular accident—Doxorubicin—liver cancer	0.00322	0.0033	CcSEcCtD
Cilazapril—Pruritus—Sorafenib—liver cancer	0.00321	0.00329	CcSEcCtD
Cilazapril—Ataxia—Epirubicin—liver cancer	0.00321	0.00329	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00316	0.00324	CcSEcCtD
Cilazapril—Liver function test abnormal—Epirubicin—liver cancer	0.00315	0.00323	CcSEcCtD
Cilazapril—Orthostatic hypotension—Epirubicin—liver cancer	0.00312	0.0032	CcSEcCtD
Cilazapril—Migraine—Doxorubicin—liver cancer	0.00311	0.00319	CcSEcCtD
Cilazapril—Diarrhoea—Sorafenib—liver cancer	0.00311	0.00318	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00307	0.00315	CcSEcCtD
Cilazapril—Face oedema—Doxorubicin—liver cancer	0.00305	0.00313	CcSEcCtD
Cilazapril—Dizziness—Sorafenib—liver cancer	0.003	0.00308	CcSEcCtD
Cilazapril—Ataxia—Doxorubicin—liver cancer	0.00297	0.00305	CcSEcCtD
Cilazapril—Liver function test abnormal—Doxorubicin—liver cancer	0.00292	0.00299	CcSEcCtD
Cilazapril—Pancreatitis—Epirubicin—liver cancer	0.00289	0.00297	CcSEcCtD
Cilazapril—Vomiting—Sorafenib—liver cancer	0.00289	0.00296	CcSEcCtD
Cilazapril—Orthostatic hypotension—Doxorubicin—liver cancer	0.00288	0.00296	CcSEcCtD
Cilazapril—Angina pectoris—Epirubicin—liver cancer	0.00287	0.00295	CcSEcCtD
Cilazapril—Rash—Sorafenib—liver cancer	0.00286	0.00293	CcSEcCtD
Cilazapril—Dermatitis—Sorafenib—liver cancer	0.00286	0.00293	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00284	0.00292	CcSEcCtD
Cilazapril—Headache—Sorafenib—liver cancer	0.00284	0.00292	CcSEcCtD
Cilazapril—Bronchitis—Epirubicin—liver cancer	0.00284	0.00291	CcSEcCtD
Cilazapril—Neutropenia—Epirubicin—liver cancer	0.00276	0.00283	CcSEcCtD
Cilazapril—Dysuria—Epirubicin—liver cancer	0.00276	0.00283	CcSEcCtD
Cilazapril—Pollakiuria—Epirubicin—liver cancer	0.00272	0.00279	CcSEcCtD
Cilazapril—Nausea—Sorafenib—liver cancer	0.0027	0.00276	CcSEcCtD
Cilazapril—Photosensitivity reaction—Epirubicin—liver cancer	0.00269	0.00276	CcSEcCtD
Cilazapril—Pancreatitis—Doxorubicin—liver cancer	0.00268	0.00274	CcSEcCtD
Cilazapril—Hyperglycaemia—Epirubicin—liver cancer	0.00266	0.00273	CcSEcCtD
Cilazapril—Angina pectoris—Doxorubicin—liver cancer	0.00266	0.00273	CcSEcCtD
Cilazapril—Bronchitis—Doxorubicin—liver cancer	0.00262	0.00269	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00261	0.00267	CcSEcCtD
Cilazapril—Renal failure—Epirubicin—liver cancer	0.00259	0.00265	CcSEcCtD
Cilazapril—Conjunctivitis—Epirubicin—liver cancer	0.00256	0.00262	CcSEcCtD
Cilazapril—Dysuria—Doxorubicin—liver cancer	0.00255	0.00262	CcSEcCtD
Cilazapril—Neutropenia—Doxorubicin—liver cancer	0.00255	0.00262	CcSEcCtD
Cilazapril—Pollakiuria—Doxorubicin—liver cancer	0.00252	0.00259	CcSEcCtD
Cilazapril—Photosensitivity reaction—Doxorubicin—liver cancer	0.00249	0.00255	CcSEcCtD
Cilazapril—Hepatobiliary disease—Epirubicin—liver cancer	0.00249	0.00255	CcSEcCtD
Cilazapril—Epistaxis—Epirubicin—liver cancer	0.00248	0.00254	CcSEcCtD
Cilazapril—Sinusitis—Epirubicin—liver cancer	0.00247	0.00253	CcSEcCtD
Cilazapril—Hyperglycaemia—Doxorubicin—liver cancer	0.00246	0.00252	CcSEcCtD
Cilazapril—Agranulocytosis—Epirubicin—liver cancer	0.00245	0.00252	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00241	0.00247	CcSEcCtD
Cilazapril—Bradycardia—Epirubicin—liver cancer	0.0024	0.00246	CcSEcCtD
Cilazapril—Renal failure—Doxorubicin—liver cancer	0.00239	0.00245	CcSEcCtD
Cilazapril—Rhinitis—Epirubicin—liver cancer	0.00237	0.00243	CcSEcCtD
Cilazapril—Conjunctivitis—Doxorubicin—liver cancer	0.00237	0.00243	CcSEcCtD
Cilazapril—Hypoaesthesia—Epirubicin—liver cancer	0.00235	0.00241	CcSEcCtD
Cilazapril—Pharyngitis—Epirubicin—liver cancer	0.00234	0.0024	CcSEcCtD
Cilazapril—Urinary tract disorder—Epirubicin—liver cancer	0.00233	0.00239	CcSEcCtD
Cilazapril—Urethral disorder—Epirubicin—liver cancer	0.00231	0.00237	CcSEcCtD
Cilazapril—Hepatobiliary disease—Doxorubicin—liver cancer	0.0023	0.00236	CcSEcCtD
Cilazapril—Epistaxis—Doxorubicin—liver cancer	0.0023	0.00235	CcSEcCtD
Cilazapril—Sinusitis—Doxorubicin—liver cancer	0.00228	0.00234	CcSEcCtD
Cilazapril—Visual impairment—Epirubicin—liver cancer	0.00228	0.00233	CcSEcCtD
Cilazapril—Agranulocytosis—Doxorubicin—liver cancer	0.00227	0.00233	CcSEcCtD
Cilazapril—Erythema multiforme—Epirubicin—liver cancer	0.00223	0.00229	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—liver cancer	0.00222	0.00228	CcSEcCtD
Cilazapril—Tinnitus—Epirubicin—liver cancer	0.0022	0.00226	CcSEcCtD
Cilazapril—Cardiac disorder—Epirubicin—liver cancer	0.00219	0.00225	CcSEcCtD
Cilazapril—Flushing—Epirubicin—liver cancer	0.00219	0.00225	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—liver cancer	0.00219	0.00225	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—liver cancer	0.00217	0.00223	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—liver cancer	0.00217	0.00222	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—liver cancer	0.00216	0.00221	CcSEcCtD
Cilazapril—Angiopathy—Epirubicin—liver cancer	0.00214	0.0022	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—liver cancer	0.00214	0.0022	CcSEcCtD
Cilazapril—Immune system disorder—Epirubicin—liver cancer	0.00213	0.00219	CcSEcCtD
Cilazapril—Chills—Epirubicin—liver cancer	0.00212	0.00217	CcSEcCtD
Cilazapril—Arrhythmia—Epirubicin—liver cancer	0.00211	0.00216	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—liver cancer	0.00211	0.00216	CcSEcCtD
Cilazapril—Alopecia—Epirubicin—liver cancer	0.00209	0.00214	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—liver cancer	0.00207	0.00212	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—liver cancer	0.00204	0.00209	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—liver cancer	0.00203	0.00208	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—liver cancer	0.00203	0.00208	CcSEcCtD
Cilazapril—Flatulence—Epirubicin—liver cancer	0.00203	0.00208	CcSEcCtD
Cilazapril—Tension—Epirubicin—liver cancer	0.00202	0.00207	CcSEcCtD
Cilazapril—Dysgeusia—Epirubicin—liver cancer	0.00201	0.00206	CcSEcCtD
Cilazapril—Nervousness—Epirubicin—liver cancer	0.002	0.00205	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—liver cancer	0.00198	0.00203	CcSEcCtD
Cilazapril—Muscle spasms—Epirubicin—liver cancer	0.00198	0.00203	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—liver cancer	0.00197	0.00202	CcSEcCtD
Cilazapril—Chills—Doxorubicin—liver cancer	0.00196	0.00201	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—liver cancer	0.00195	0.002	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—liver cancer	0.00193	0.00198	CcSEcCtD
Cilazapril—Ill-defined disorder—Epirubicin—liver cancer	0.00191	0.00196	CcSEcCtD
Cilazapril—Anaemia—Epirubicin—liver cancer	0.0019	0.00195	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—liver cancer	0.00187	0.00192	CcSEcCtD
Cilazapril—Tension—Doxorubicin—liver cancer	0.00187	0.00191	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—liver cancer	0.00186	0.00191	CcSEcCtD
Cilazapril—Malaise—Epirubicin—liver cancer	0.00185	0.0019	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—liver cancer	0.00185	0.00189	CcSEcCtD
Cilazapril—Vertigo—Epirubicin—liver cancer	0.00185	0.00189	CcSEcCtD
Cilazapril—Syncope—Epirubicin—liver cancer	0.00184	0.00189	CcSEcCtD
Cilazapril—Leukopenia—Epirubicin—liver cancer	0.00184	0.00189	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—liver cancer	0.00183	0.00188	CcSEcCtD
Cilazapril—Palpitations—Epirubicin—liver cancer	0.00182	0.00186	CcSEcCtD
Cilazapril—Loss of consciousness—Epirubicin—liver cancer	0.00181	0.00185	CcSEcCtD
Cilazapril—Cough—Epirubicin—liver cancer	0.00179	0.00184	CcSEcCtD
Cilazapril—Hypertension—Epirubicin—liver cancer	0.00177	0.00182	CcSEcCtD
Cilazapril—Nateglinide—ALB—liver cancer	0.00177	0.071	CrCbGaD
Cilazapril—Ill-defined disorder—Doxorubicin—liver cancer	0.00176	0.00181	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—liver cancer	0.00176	0.0018	CcSEcCtD
Cilazapril—Chest pain—Epirubicin—liver cancer	0.00175	0.00179	CcSEcCtD
Cilazapril—Myalgia—Epirubicin—liver cancer	0.00175	0.00179	CcSEcCtD
Cilazapril—Arthralgia—Epirubicin—liver cancer	0.00175	0.00179	CcSEcCtD
Cilazapril—Anxiety—Epirubicin—liver cancer	0.00174	0.00179	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00174	0.00178	CcSEcCtD
Cilazapril—Discomfort—Epirubicin—liver cancer	0.00173	0.00177	CcSEcCtD
Cilazapril—Malaise—Doxorubicin—liver cancer	0.00171	0.00176	CcSEcCtD
Cilazapril—Dry mouth—Epirubicin—liver cancer	0.00171	0.00176	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—liver cancer	0.00171	0.00175	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—liver cancer	0.00171	0.00175	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—liver cancer	0.0017	0.00175	CcSEcCtD
Cilazapril—Confusional state—Epirubicin—liver cancer	0.00169	0.00173	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—liver cancer	0.00168	0.00172	CcSEcCtD
Cilazapril—Oedema—Epirubicin—liver cancer	0.00168	0.00172	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—liver cancer	0.00167	0.00171	CcSEcCtD
Cilazapril—Cough—Doxorubicin—liver cancer	0.00166	0.0017	CcSEcCtD
Cilazapril—Shock—Epirubicin—liver cancer	0.00165	0.00169	CcSEcCtD
Cilazapril—Thrombocytopenia—Epirubicin—liver cancer	0.00164	0.00168	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—liver cancer	0.00164	0.00168	CcSEcCtD
Cilazapril—Tachycardia—Epirubicin—liver cancer	0.00164	0.00168	CcSEcCtD
Cilazapril—Skin disorder—Epirubicin—liver cancer	0.00163	0.00167	CcSEcCtD
Cilazapril—Hyperhidrosis—Epirubicin—liver cancer	0.00162	0.00166	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—liver cancer	0.00162	0.00166	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—liver cancer	0.00162	0.00166	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—liver cancer	0.00162	0.00166	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—liver cancer	0.00161	0.00165	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00161	0.00165	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—liver cancer	0.0016	0.00164	CcSEcCtD
Cilazapril—Anorexia—Epirubicin—liver cancer	0.0016	0.00164	CcSEcCtD
Cilazapril—Dry mouth—Doxorubicin—liver cancer	0.00158	0.00162	CcSEcCtD
Cilazapril—Hypotension—Epirubicin—liver cancer	0.00157	0.00161	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—liver cancer	0.00156	0.0016	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—liver cancer	0.00155	0.00159	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00153	0.00157	CcSEcCtD
Cilazapril—Shock—Doxorubicin—liver cancer	0.00153	0.00157	CcSEcCtD
Cilazapril—Thrombocytopenia—Doxorubicin—liver cancer	0.00152	0.00156	CcSEcCtD
Cilazapril—Insomnia—Epirubicin—liver cancer	0.00152	0.00156	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—liver cancer	0.00151	0.00155	CcSEcCtD
Cilazapril—Skin disorder—Doxorubicin—liver cancer	0.00151	0.00155	CcSEcCtD
Cilazapril—Paraesthesia—Epirubicin—liver cancer	0.00151	0.00154	CcSEcCtD
Cilazapril—Hyperhidrosis—Doxorubicin—liver cancer	0.0015	0.00154	CcSEcCtD
Cilazapril—Dyspnoea—Epirubicin—liver cancer	0.0015	0.00153	CcSEcCtD
Cilazapril—Somnolence—Epirubicin—liver cancer	0.00149	0.00153	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—liver cancer	0.00148	0.00152	CcSEcCtD
Cilazapril—Dyspepsia—Epirubicin—liver cancer	0.00148	0.00151	CcSEcCtD
Cilazapril—Decreased appetite—Epirubicin—liver cancer	0.00146	0.0015	CcSEcCtD
Cilazapril—Hypotension—Doxorubicin—liver cancer	0.00145	0.00149	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Epirubicin—liver cancer	0.00145	0.00149	CcSEcCtD
Cilazapril—Fatigue—Epirubicin—liver cancer	0.00145	0.00148	CcSEcCtD
Cilazapril—Constipation—Epirubicin—liver cancer	0.00143	0.00147	CcSEcCtD
Cilazapril—Pain—Epirubicin—liver cancer	0.00143	0.00147	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00141	0.00145	CcSEcCtD
Cilazapril—Insomnia—Doxorubicin—liver cancer	0.0014	0.00144	CcSEcCtD
Cilazapril—Paraesthesia—Doxorubicin—liver cancer	0.00139	0.00143	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—liver cancer	0.00138	0.00142	CcSEcCtD
Cilazapril—Feeling abnormal—Epirubicin—liver cancer	0.00138	0.00142	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—liver cancer	0.00138	0.00142	CcSEcCtD
Cilazapril—Gastrointestinal pain—Epirubicin—liver cancer	0.00137	0.00141	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—liver cancer	0.00137	0.0014	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—liver cancer	0.00135	0.00138	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00134	0.00137	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—liver cancer	0.00134	0.00137	CcSEcCtD
Cilazapril—Urticaria—Epirubicin—liver cancer	0.00133	0.00137	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—liver cancer	0.00133	0.00136	CcSEcCtD
Cilazapril—Pain—Doxorubicin—liver cancer	0.00133	0.00136	CcSEcCtD
Cilazapril—Abdominal pain—Epirubicin—liver cancer	0.00133	0.00136	CcSEcCtD
Cilazapril—Feeling abnormal—Doxorubicin—liver cancer	0.00128	0.00131	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—liver cancer	0.00127	0.0013	CcSEcCtD
Cilazapril—Hypersensitivity—Epirubicin—liver cancer	0.00124	0.00127	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—liver cancer	0.00123	0.00126	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—liver cancer	0.00123	0.00126	CcSEcCtD
Cilazapril—Asthenia—Epirubicin—liver cancer	0.0012	0.00123	CcSEcCtD
Cilazapril—Pruritus—Epirubicin—liver cancer	0.00119	0.00122	CcSEcCtD
Cilazapril—Diarrhoea—Epirubicin—liver cancer	0.00115	0.00118	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—liver cancer	0.00114	0.00117	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—liver cancer	0.00111	0.00114	CcSEcCtD
Cilazapril—Dizziness—Epirubicin—liver cancer	0.00111	0.00114	CcSEcCtD
Cilazapril—Pruritus—Doxorubicin—liver cancer	0.0011	0.00113	CcSEcCtD
Cilazapril—Vomiting—Epirubicin—liver cancer	0.00107	0.00109	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—liver cancer	0.00106	0.00109	CcSEcCtD
Cilazapril—Rash—Epirubicin—liver cancer	0.00106	0.00108	CcSEcCtD
Cilazapril—Dermatitis—Epirubicin—liver cancer	0.00106	0.00108	CcSEcCtD
Cilazapril—Headache—Epirubicin—liver cancer	0.00105	0.00108	CcSEcCtD
Cilazapril—Dizziness—Doxorubicin—liver cancer	0.00103	0.00105	CcSEcCtD
Cilazapril—Nausea—Epirubicin—liver cancer	0.000996	0.00102	CcSEcCtD
Cilazapril—Vomiting—Doxorubicin—liver cancer	0.000987	0.00101	CcSEcCtD
Cilazapril—Rash—Doxorubicin—liver cancer	0.000979	0.001	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—liver cancer	0.000978	0.001	CcSEcCtD
Cilazapril—Headache—Doxorubicin—liver cancer	0.000972	0.000997	CcSEcCtD
Cilazapril—Nausea—Doxorubicin—liver cancer	0.000922	0.000945	CcSEcCtD
